Digestive System Diseases

Rheinland Klinikum Neuss is conducting research aimed at improving outcomes for patients with metastatic colorectal cancer. The study compares the benefit of adding chemotherapy after surgery or ablation with standard follow‑up, seeking to enhance disease control.

  • Evaluation of post‑resection systemic therapy
  • Integration of ablation with chemotherapy
  • Assessment of long‑term survival and recurrence rates

These efforts reflect the site’s commitment to advancing treatment strategies within the digestive oncology field.

Neoplasms

At Rheinland Klinikum Neuss, investigators are exploring a less toxic regimen for patients with advanced stage Hodgkin lymphoma. The trial aims to reduce treatment‑related morbidity while maintaining efficacy, offering a potential improvement in quality of life.

  • Comparison of BrECADD versus escalated BEACOPP
  • Measurement of treatment‑related morbidity
  • Evaluation of progression‑free survival as a co‑primary endpoint

This work underscores the institution’s focus on innovative cancer therapies and patient‑centered care in the hematologic malignancy arena.